Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy

W I Gonsalves,S V Rajkumar,M A Gertz,A Dispenzieri,M Q Lacy,F K Buadi,D Dingli,R S Go,N Leung,P Kapoor,S R Hayman,J A Lust,S J Russell,S R Zeldenrust,Y L Hwa,T V Kourelis,R A Kyle,S K Kumar

BONE MARROW TRANSPLANTATION（2016）

Cited 15|Views11

No score

Abstract

Autologous stem cell transplant (ASCT) remains an integral part of the treatment of eligible patients with multiple myeloma (MM). It is usually performed either in the upfront setting as consolidation after induction therapy or in a delayed fashion for management of relapsed disease.

Translated text

Key words

BMT,transplantation,stem cells,progenitor cells,allografting,autografting,graft-versus-host disease

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined